About this trial
The purpose of this Long-Term Follow-Up (LTFU) study is to monitor participants who have previously received TSC-100 or TSC-101 TCR-T therapies in the TSCAN-001 study. Participants will be monitored for 15 years from the date of TCR-T cell therapy administration to assess long-term safety and efficacy.
Eligibility criteria
Qualifiers
Participants who received a TCR-T cellular therapy in a clinical study sponsored by TScan Therapeutics.
Signed informed consent.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Observational
Treatment groups
1,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov